PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

25 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮
Lay all publications on this page into basket
1.
Aronsson, C.A.* et al.: Dietary intake and body mass index influence the risk of islet autoimmunity in genetically at-risk children: A mediation analysis using the TEDDY Cohort. Pediatr. Diabetes 2023:11 (2023)
2.
Besser, R.E.J.* et al.: ISPAD clinical practice consensus guidelines 2022: Stages of type 1 diabetes in children and adolescents. Pediatr. Diabetes 23, 1175-1187 (2022)
3.
Houben, J.* et al.: The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study. Pediatr. Diabetes 23, 1707-1716 (2022)
4.
Salami, F.* et al.: HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children. Pediatr. Diabetes 23, 1586-1593 (2022)
5.
Zielmann, M.L.* et al.: Autoantibodies against ATP4A are a feature of the abundant autoimmunity that develops in first-degree relatives of patients with type 1 diabetes. Pediatr. Diabetes 23, 714-720 (2022)
6.
Smith, L.B.* ; Lynch, K.F.* ; Driscoll, K.A.* ; Johnson, S.B.* & TEDDY Study Group (Wendel, L. ; Winkler, C. ; Ziegler, A.-G. ; Hummel, S.): Parental monitoring for type 1 diabetes in genetically at-risk young children: The TEDDY study. Pediatr. Diabetes 22, 717-728 (2021)
7.
Jacobsen, L.M.* et al.: Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children. Pediatr. Diabetes 20, 263-270 (2019)
8.
Silvis, K.* et al.: Maternal dietary supplement use and development of islet autoimmunity in the offspring: TEDDY study. Pediatr. Diabetes 20, 86-92 (2019)
9.
Winkler, C. et al.: Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results. Pediatr. Diabetes 20, 720-727 (2019)
10.
Couper, J.J.* et al.: ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents. Pediatr. Diabetes 19, 20-27 (2018)
11.
Frohnert, B.I.* et al.: Prediction of type 1 diabetes using a genetic risk model in the Diabetes Autoimmunity Study in the Young. Pediatr. Diabetes 19, 277-283 (2018)
12.
Heinrich, M. et al.: Fasting hypoglycemia is associated with disease progression in presymptomatic early stage type 1 diabetes. Pediatr. Diabetes 19, 1238-1242 (2018)
13.
Smith, L.B.* et al.: Family adjustment to diabetes diagnosis in children: Can participation in a study on type 1 diabetes genetic risk be helpful? Pediatr. Diabetes 19, 1025-1033 (2018)
14.
Steck, A.K.* et al.: Residual beta-cell function in diabetes children followed and diagnosed in the TEDDY study compared to community controls. Pediatr. Diabetes 18, 794-802 (2017)
15.
Yassouridis, C.* ; Leisch, F.* ; Winkler, C. ; Ziegler, A.-G. & Beyerlein, A.: Associations of growth patterns and islet autoimmunity in children with increased risk for type 1 diabetes: A functional analysis approach. Pediatr. Diabetes 18, 103-110 (2017)
16.
Warncke, K. et al.: Vascular risk factors in children, adolescents, and young adults with type 1 diabetes complicated by celiac disease: Results from the DPV initiative. Pediatr. Diabetes 17, 191-198 (2016)
17.
Beyerlein, A. et al.: Early infant growth is associated with the risk of islet autoimmunity in genetically susceptible children. Pediatr. Diabetes 15, 534-542 (2014)
18.
Couper, J.J.* et al.: Phases of type 1 diabetes in children and adolescents. Pediatr. Diabetes 15, 18-25 (2014)
19.
Elding Larsson, H.* et al.: Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr. Diabetes 15, 118-126 (2014)
20.
Giannopoulou, E.Z. et al.: Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: A non-randomized, controlled trial. Pediatr. Diabetes 15, 100-109 (2014)
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮